In a 67‑year‑old man with two days of abdominal pain, an initial hypertensive crisis (220/120 mm Hg) followed by hypotension (unrecordable, then 120/80 mm Hg after fluid resuscitation), a modest rise in high‑sensitivity troponin (0.55 ng/dL at 2 h, >0.10 ng/dL at 6 h), CK‑MB peak 1000 U/L falling to 562 U/L, and transient T‑wave inversions on ECG, is this myocardial injury clinically significant (type 2 myocardial infarction) and what is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Type 2 Myocardial Infarction with Hemodynamic Instability

This 67-year-old man experienced a type 2 myocardial infarction (supply-demand mismatch) triggered by hypertensive crisis followed by hypotensive shock, and the troponin elevation is clinically significant, requiring urgent echocardiography, continuous cardiac monitoring, treatment of the underlying hemodynamic instability, and consideration of coronary angiography if ischemic symptoms or high-risk ECG features develop.

Understanding the Clinical Picture

This patient's presentation represents a classic type 2 MI scenario where extreme blood pressure fluctuations caused myocardial injury without coronary artery occlusion:

  • Hypertensive crisis (220/120 mmHg) dramatically increased myocardial oxygen demand through elevated afterload and wall stress 1, 2
  • Subsequent hypotension (unrecordable BP) created a supply-demand mismatch by reducing coronary perfusion pressure 1, 3
  • The troponin pattern shows initial elevation (0.55 ng/dL at 2 hours) with subsequent rise (>0.10 ng/dL at 6 hours), confirming acute myocardial injury 1, 3
  • Transient T-wave inversions that resolved suggest dynamic ischemia from the hemodynamic stress rather than fixed coronary occlusion 1

The CK-MB values (1000 U/L falling to 562 U/L) are confusing as written—if these represent actual CK-MB mass values, they are extraordinarily high and suggest massive myocardial necrosis 1. However, the troponin values seem relatively modest for such extensive injury, raising the possibility of laboratory error or unit confusion.

Why This Is Type 2 MI, Not Type 1

Several features distinguish this from acute coronary syndrome with plaque rupture:

  • Hemodynamic triggers (hypertensive crisis → hypotension) preceded the troponin rise, indicating supply-demand mismatch rather than thrombotic occlusion 1, 3
  • Transient ECG changes that resolved suggest reversible ischemia from hemodynamic stress rather than persistent coronary occlusion 1
  • Clinical context of abdominal pain with hemodynamic collapse points to a non-cardiac primary process (possibly intra-abdominal catastrophe, sepsis, or hypovolemia) 1, 3

Type 2 MI accounts for approximately 5% of troponin elevations and carries significant mortality risk despite the absence of coronary thrombosis 1, 3.

Immediate Diagnostic Priorities

Serial Troponin Monitoring

  • Obtain troponin every 3-6 hours to document the dynamic pattern; a ≥20% change with at least one value above the 99th percentile confirms acute myocardial necrosis 1, 3
  • Rising troponin in this context indicates ongoing myocardial injury from persistent hemodynamic instability 3, 4

ECG Assessment

  • Repeat 12-lead ECGs every 15-30 minutes if symptoms persist or hemodynamics remain unstable 1, 4
  • Look for ST-segment depression ≥1 mm, new T-wave inversions, or transient ST-elevation that would suggest superimposed type 1 MI requiring urgent angiography 1, 3, 4
  • Add posterior leads (V7-V9) and right-sided leads (V3R-V4R) if standard leads remain non-diagnostic but clinical suspicion is high 3

Urgent Echocardiography

  • Perform bedside transthoracic echo immediately to assess left ventricular function, regional wall motion abnormalities, valvular pathology (especially acute mitral regurgitation from papillary muscle ischemia), and to exclude mechanical complications 3, 4, 5
  • Assess for right ventricular strain that might suggest pulmonary embolism as an alternative diagnosis 3

Management Algorithm

Stabilize Hemodynamics First

  • Maintain systolic BP 100-120 mmHg with careful fluid resuscitation; avoid aggressive fluid boluses that could precipitate pulmonary edema in the setting of myocardial injury 6
  • If hypotension persists despite fluids, initiate vasopressor support (norepinephrine preferred) to maintain adequate coronary perfusion pressure 5
  • Continuous cardiac monitoring is mandatory because rising troponin patients have increased risk of ventricular arrhythmias 3, 4

Identify and Treat the Underlying Cause

The abdominal pain and hemodynamic collapse suggest:

  • Intra-abdominal catastrophe (ruptured viscus, mesenteric ischemia, ruptured abdominal aortic aneurysm) requiring urgent CT abdomen/pelvis with IV contrast 1
  • Septic shock from intra-abdominal source—check lactate, procalcitonin, blood cultures, and initiate broad-spectrum antibiotics if sepsis is suspected 3
  • Hypovolemic shock from occult bleeding—check hemoglobin, coagulation studies 3

Cardiac-Specific Management

If ischemic symptoms develop or ECG shows high-risk features (ST-depression ≥1 mm):

  • Initiate ACS protocol immediately: aspirin 162-325 mg, P2Y12 inhibitor (ticagrelor or prasugrel), anticoagulation with unfractionated heparin or enoxaparin 3, 4
  • Arrange urgent coronary angiography within 24 hours if GRACE score >140 or high-risk features present 3, 4
  • Consider GP IIb/IIIa inhibitor (eptifibatide or tirofiban) in high-risk patients proceeding to angiography 3, 4

If no ischemic symptoms and ECG remains non-diagnostic:

  • Do NOT routinely start dual antiplatelet therapy—type 2 MI is managed by treating the underlying hemodynamic trigger, not with antithrombotic therapy 1, 3
  • Focus on optimizing hemodynamics and treating the primary non-cardiac condition 1, 3
  • High-intensity statin therapy should be initiated regardless, as any troponin elevation predicts increased cardiovascular risk 3, 4

Prognostic Implications

  • Any troponin elevation confers approximately 3-fold increased risk of death or MI at 30 days, independent of the underlying cause 3, 7
  • Type 2 MI carries similar or worse prognosis compared to type 1 MI, with 5-year mortality approaching 70% 7
  • The magnitude of troponin elevation correlates directly with mortality risk; values >5× the upper reference limit have >90% positive predictive value for significant myocardial damage 3

Critical Pitfalls to Avoid

  • Never dismiss troponin elevation as "just demand ischemia"—it represents genuine myocardial necrosis with poor prognosis 3, 7
  • Do not reflexively start dual antiplatelet therapy without evidence of type 1 MI; type 2 MI is managed by correcting the hemodynamic trigger 1, 3
  • Never rely on a single troponin measurement—serial testing is mandatory to establish the dynamic pattern 1, 3
  • Do not attribute troponin elevation solely to hypertension or hypotension without excluding concurrent type 1 MI through serial ECGs and clinical assessment 3, 8
  • Avoid aggressive BP lowering in the acute phase; reduce BP by only 20-25% in the first hour to prevent worsening coronary perfusion 2, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypertensive crisis.

Cardiology in review, 2010

Guideline

Causes of Elevated Troponin Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Coronary Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cardiogenic Shock in Acute Myocardial Infarction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Therapeutic Approach to Hypertension Urgencies and Emergencies in the Emergency Room.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.